Textbook - Chapter 12 Ingestive Behaviour
Don W. Fawcett/Science Source
Ingestive behavior involves the regulation of drinking and eating to maintain the body's internal balance (homeostasis).
Drinking is controlled by physiological regulatory mechanisms that detect changes in the body's fluid balance and trigger thirst.
There are two types of thirst: osmometric thirst (caused by increased solute concentration in the body fluids) and volumetric thirst (caused by decreased blood volume).
Neural mechanisms of thirst involve brain regions that monitor fluid balance and initiate drinking behavior.
Metabolism refers to the chemical processes that maintain life, including the storage and use of energy.
The body has two main energy reservoirs: the short-term reservoir (mainly in the liver and muscles as glycogen) and the long-term reservoir (fat stored in adipose tissue).
The fasting phase occurs when the digestive tract is empty, and the body relies on stored energy.
The absorptive phase occurs after eating, when nutrients are absorbed and stored.
Meal initiation is influenced by environmental cues, gastric signals (such as stomach contractions), and metabolic signals (like low glucose or fatty acid levels).
Meal termination (satiety) is regulated by short-term signals, including sensory input (taste, smell), gastric distension, intestinal signals (nutrient detection), liver signals, and hormonal factors like insulin.
Adipose tissue releases signals (such as leptin) that inform the brain about long-term energy stores.
Brain mechanisms involved in ingestive behavior include the brain stem and hypothalamus, which integrate signals to regulate hunger and satiety.
Obesity can result from genetic, metabolic, and environmental factors, and treatments may include lifestyle changes, medication, or surgery.
Eating disorders (such as anorexia nervosa and bulimia) have complex causes, including psychological and biological factors, and require specialized treatment approaches.
Learning Objectives
Physiological regulatory mechanisms maintain homeostasis by detecting deviations from set points and initiating corrective responses to restore balance, involving coordinated actions of multiple body systems.
Osmometric thirst is triggered by increased solute concentration in body fluids, leading to water movement out of cells, while volumetric thirst results from decreased blood volume, often due to blood loss or dehydration.
Neural mechanisms of thirst involve the hypothalamus, which detects changes in fluid balance and initiates thirst-driven behaviors to restore equilibrium.
The short-term energy reservoir is primarily located in the liver and muscles, storing glycogen for immediate energy needs, while the long-term reservoir is adipose tissue, storing fat for prolonged energy supply.
During the fasting phase, your body uses glucose from glycogen stores first, then shifts to fat and amino acids for energy; in the absorptive phase, glucose from food is used, and excess nutrients are stored as glycogen and fat.
Environmental cues (like time of day, sight, and smell of food) and hormonal signals (such as ghrelin) help initiate meals, while metabolic signals (like low glucose or fatty acid levels) also trigger hunger.
Short-term satiety signals come from the stomach (stretch receptors), intestines (nutrient detection), and liver (nutrient processing), signaling fullness and meal termination.
Insulin acts as a satiety signal by promoting glucose uptake and storage, while adipose tissue releases long-term satiety signals (like leptin) to regulate overall energy balance.
The brain stem and hypothalamus are central to regulating eating, integrating hunger and satiety signals to control food intake.
Obesity is influenced by environmental factors (diet, lifestyle), physical activity, and genetics, while treatments include behavioral interventions, medications, surgery, and addressing psychological factors like stress and reinforcement.
Eating disorders involve complex interactions between brain changes, genetics, starvation, and excessive exercise, with interventions including therapy, nutritional support, and medical management.
Prader-Willi syndrome is a genetic disorder (chromosome 15 deletion) affecting hypothalamic function, leading to insatiable hunger, low muscle tone, and obesity, illustrating the critical role of neural and hormonal mechanisms in appetite regulation.
Homeostasis is achieved through the coordinated actions of the digestive, respiratory, circulatory, and excretory systems, along with behaviors that ensure adequate intake of food, water, and minerals.
Chapter Outline
Thirst is regulated by physiological mechanisms that respond to changes in body fluid balance, with two main types: osmometric thirst (triggered by increased solute concentration in extracellular fluid) and volumetric thirst (triggered by decreased blood volume).
Neural mechanisms of thirst involve the brain detecting changes in blood osmolality and volume, activating thirst and drinking behaviors to restore homeostasis.
Metabolism refers to the chemical processes that maintain life, including energy storage and usage through short-term (glycogen in the liver) and long-term (fat in adipose tissue) reservoirs.
The fasting phase occurs when the digestive tract is empty, and the body relies on stored energy, while the absorptive phase happens after eating, when nutrients are absorbed and stored.
Meal initiation is influenced by environmental cues, gastric signals (stomach contractions), and metabolic signals (changes in blood glucose and fatty acids).
Meal termination (satiety) is regulated by short-term signals (stomach distension, nutrient detection in intestines), environmental and sensory factors, and metabolic feedback from the liver and insulin levels.
Adipose tissue releases signals (like leptin) that inform the brain about long-term energy stores, influencing hunger and satiety.
Brain mechanisms, particularly in the brain stem and hypothalamus, integrate signals from the body to regulate eating and drinking behaviors.
Obesity can result from genetic, environmental, and physiological factors, and treatments may include lifestyle changes, medications, or surgery.
Eating disorders have complex causes, including psychological and biological factors, and require multifaceted treatment approaches.
Learning Objectives
Physiological regulatory mechanisms maintain homeostasis by detecting deviations from a set point and activating processes to restore balance, involving systems like digestive, respiratory, circulatory, and excretory.
Osmometric thirst is triggered by increased solute concentration in body fluids, while volumetric thirst results from decreased blood volume; both initiate drinking behavior but are activated by different physiological cues.
Neural mechanisms of thirst involve brain regions such as the hypothalamus, which integrates signals about fluid balance and initiates thirst responses.
Short-term energy reservoirs are primarily located in the liver and muscles, storing glycogen for immediate energy needs, while long-term reservoirs are found in adipose tissue, storing fat for prolonged energy supply.
During the fasting phase, the body uses glucose from glycogen, then shifts to fat and amino acids for energy; in the absorptive phase, nutrients from food are used directly, and excess is stored.
Environmental signals (like time of day, food cues) and hormonal signals (such as ghrelin) help initiate meals, while metabolic signals (like low glucose or fatty acid levels) also play a role.
Short-term satiety signals arise from the stomach, intestines, and liver, providing feedback to stop eating; insulin and signals from adipose tissue (like leptin) contribute to longer-term regulation.
Satiety is influenced by environmental factors (such as portion size, social context) and sensory factors (taste, smell, appearance of food).
The brain stem and hypothalamus are key brain regions regulating eating, integrating signals of hunger and satiety.
Obesity is influenced by environmental factors, physical activity, and genetics, and can be treated through behavioral, pharmacological, surgical, and reinforcement-based interventions.
Eating disorders involve changes in brain function, effects of starvation, excessive exercise, and genetic predispositions; interventions include therapy, nutritional support, and medical management.
Prader-Willi syndrome is a genetic disorder affecting hypothalamic function, leading to impaired regulation of hunger and satiety, and is caused by deletions on chromosome 15, typically from the paternal side.
Drinking
Ingestive behaviors like eating and drinking are regulated by physiological mechanisms that help maintain stable internal conditions (homeostasis) despite changes in the external environment.
Homeostasis involves keeping internal characteristics, such as body temperature, constant even when external factors, like environmental temperature, fluctuate.
Understanding these regulatory mechanisms is essential for explaining how and why organisms engage in behaviors like eating and drinking.
Physiological Regulatory Mechanisms
A physiological regulatory mechanism has four essential components: the system variable (the characteristic being regulated), the set point (the optimal value for the variable), a detector (which monitors the variable), and a correctional mechanism (which restores the variable to the set point).
Negative feedback regulates the system: The effect produced by the correctional mechanism reduces or stops the action, maintaining stability. For example, in a room with a thermostat, the air temperature is the system variable, the thermostat is the detector, and the heater is the correctional mechanism. When the temperature drops below the set point, the heater turns on; when the temperature rises, the heater turns off.
Ingestive behaviors act as correctional mechanisms: These behaviors (like drinking or eating) replenish depleted stores of water or nutrients in the body.
Satiety mechanisms are necessary due to physiological delays: Because there is a delay between ingesting water or nutrients and their absorption into the body, satiety mechanisms in the brain reduce hunger or thirst before the system variable (e.g., body fluid levels) is actually restored. These mechanisms monitor the activity of the correctional mechanism (e.g., drinking), not the system variable itself.
Satiety mechanisms anticipate replenishment: They stop ingestive behaviors once enough has been consumed to eventually restore balance, even before the actual physiological need is met. For example, after drinking water, you stop feeling thirsty before the water has been absorbed into your cells, due to signals from your digestive system to the brain.
Two Types of Thirst
Osmometric thirst is triggered by increased solute concentration in the interstitial fluid, causing water to leave cells via osmosis and leading to cell shrinkage. Osmoreceptors, mainly located in the organum vasculosum of the lamina terminalis (OVLT) and subfornical organ (SFO), detect these changes and alter their firing rate to signal thirst or satiety. Eating salty foods induces pure osmometric thirst, as absorbed salt increases blood plasma concentration, drawing water from cells.
Volumetric thirst arises when blood plasma volume (intravascular fluid) decreases, such as through bleeding, vomiting, or diarrhea, leading to hypovolemia. Detector cells in the kidneys and heart monitor blood volume; reduced blood flow to the kidneys triggers the release of angiotensin, which stimulates drinking, salt appetite, water and salt retention, and increased blood pressure. Baroreceptors in the atria of the heart also detect low blood volume and promote drinking behavior.
Both osmometric and volumetric thirst activate neural circuits involving the lamina terminalis and anterior cingulate cortex, but they are distinguished by their physiological triggers and receptor locations. Osmometric thirst is primarily a response to cellular dehydration and solute concentration, while volumetric thirst is a response to decreased blood volume and involves hormonal and cardiovascular mechanisms. Volumetric thirst also leads to a salt appetite due to concurrent sodium loss.
Neural Mechanisms of Thirst
Osmometric and volumetric thirst are regulated by distinct but interconnected neural mechanisms. Osmometric thirst is triggered when interstitial fluid draws water out of cells, detected by osmoreceptors in the OVLT (organum vasculosum of the lamina terminalis) and SFO (subfornical organ). Volumetric thirst is primarily triggered by blood loss or decreased blood flow, leading to the production of angiotensin, which acts on the SFO.
The lamina terminalis, particularly the median preoptic nucleus, integrates signals for thirst. The median preoptic nucleus receives input from angiotensin-sensitive neurons in the SFO (for volumetric thirst), osmoreceptors in the OVLT (for osmometric thirst), and the nucleus of the solitary tract (which relays information from atrial baroreceptors). This integration is crucial for initiating drinking behavior.
Angiotensin acts outside the blood-brain barrier to stimulate thirst. Because angiotensin cannot cross the blood-brain barrier, it acts on the SFO, which is outside this barrier. Activation of SFO neurons by angiotensin increases their firing rate and stimulates drinking; blocking angiotensin receptors or destroying the SFO abolishes this response.
The median preoptic nucleus is essential for the control of drinking. Lesions in this nucleus cause severe deficits in osmometric thirst, indicating its role as an integrating center for thirst signals. It sends efferent connections to other brain regions to control drinking behavior.
Damage to the lamina terminalis can result in adipsia (lack of thirst). Individuals with such damage do not feel thirst even when physiologically dehydrated and must consciously drink water to survive.
Physiological regulatory mechanisms involve four components: a system variable (what is regulated), a set point (optimal value), a detector (measures the variable), and a correctional mechanism (restores balance). Satiety mechanisms are also necessary to anticipate the delayed effects of eating and drinking.
The anterior cingulate cortex is involved in the conscious sensation of thirst. It receives information from the OVLT via the dorsal midline nucleus of the thalamus and is activated during osmometric thirst.
What Is Metabolism?
Eating behavior is complex and essential for survival, driven by the need to obtain a variety of nutrients (carbohydrates, fats, amino acids, vitamins, minerals) for both building body structures and providing energy.
Food serves two main purposes: supplying building blocks for organ maintenance and fuel for movement and heat production; most consumed molecules are used as fuel.
The body relies on nutrient reservoirs to maintain energy when the digestive tract is empty: the short-term reservoir stores carbohydrates, while the long-term reservoir stores fats.
There are two metabolic phases: the fasting phase (when the digestive tract is empty and the body uses stored nutrients) and the absorptive phase (when the digestive tract is full and nutrients are absorbed directly).
The nervous system uses different reservoirs depending on activity and time of day: during fasting (e.g., sleeping, working, exercising, missed meals), the short-term reservoir is used first, and the long-term reservoir is used when short-term stores are depleted; during the absorptive phase (eating), no reservoir is used.
Understanding metabolism is crucial for grasping ingestive behaviors and the physiological mechanisms that regulate eating, body weight, and meal initiation/termination.
Serious eating disorders such as obesity and anorexia nervosa are linked to disruptions in these physiological processes and remain challenging to treat, highlighting the importance of understanding metabolism and ingestive behavior.
The Short-Term Reservoir
The short-term reservoir stores energy for several hours between meals and is located in the liver and muscle cells, primarily as glycogen, an insoluble carbohydrate.
Liver cells convert glucose into glycogen for storage, a process stimulated by insulin, a hormone produced by the pancreas when glucose is abundant in the blood.
When blood glucose levels drop after food absorption, the pancreas stops releasing insulin and starts secreting glucagon, which triggers the conversion of glycogen back into glucose for release into the bloodstream.
The main function of the liver’s carbohydrate reservoir is to supply glucose to the central nervous system (CNS), especially during fasting periods such as overnight.
The chemical process can be summarized as:
Forward reaction:
Backward reaction:
The liver’s glycogen stores (about 300 calories) can fuel the CNS for a few hours; if not replenished by eating, the body must rely on long-term energy stores.
The Long-Term Reservoir
The long-term energy reservoir in your body is adipose tissue (fat tissue), which stores energy as triglycerides.
Triglycerides are molecules made of one glycerol (a soluble carbohydrate) and three fatty acids (stearic, oleic, and palmitic acids).
Adipose tissue is located under your skin and in the abdominal cavity, and its cells can absorb nutrients, convert them to triglycerides, and expand in size as they store more fat.
The main difference between obese and non-obese individuals is the size of their fat cells, not the number; larger fat cells contain more triglycerides.
During fasting, when short-term carbohydrate stores are depleted, fat cells break down triglycerides into fatty acids and glycerol, releasing them into the bloodstream.
Most body cells use fatty acids for energy during fasting, while the brain relies on glucose, which is supplied by the liver converting glycerol into glucose.
The sympathetic nervous system stimulates the breakdown of triglycerides through direct neural signals and the release of hormones (glucagon and catecholamines).
Body cells need insulin to absorb and use glucose, but brain cells do not require insulin and can take up glucose at any time, ensuring the brain’s energy supply is prioritized.
Fasting Phase
During the fasting phase, blood glucose levels fall, causing the pancreas to stop secreting insulin and start secreting glucagon.
The absence of insulin prevents most body cells from using glucose, reserving available glucose for the central nervous system (CNS).
Glucagon signals the liver to convert glycogen (short-term carbohydrate reservoir) into glucose, supplying the CNS.
Glucagon and lack of insulin, along with sympathetic nervous system activity, prompt fat cells to break down triglycerides (long-term fat reservoir) into fatty acids and glycerol.
Fatty acids are used by most of the body (especially muscles) for energy, while glycerol is converted by the liver into glucose for the brain.
If fasting continues, muscle proteins are broken down into amino acids, which can be metabolized by all body tissues except the CNS.
In the absorptive phase (when food is present), carbohydrates are broken down into glucose, proteins into amino acids, and fats remain as fats.
Rising blood glucose triggers insulin secretion, allowing all body cells to use glucose for energy.
Excess glucose is stored as glycogen (short-term) or converted to fat (long-term); excess amino acids are used for protein synthesis or converted to fat.
Glucose provides energy to both muscles and the brain during the absorptive phase.
Absorptive Phase
During the absorptive phase, nutrients from food are absorbed and processed differently: glucose is used immediately for energy by all cells (due to high insulin), excess glucose is stored as glycogen (short-term reservoir) or converted to fat, amino acids are used for protein synthesis or converted to fat, and fats are stored in adipose tissue.
Glucose metabolism: Blood glucose rises after a meal, triggering increased parasympathetic activity and insulin secretion, which allows all body cells to use glucose and promotes storage of excess glucose as glycogen in the liver and muscles; any remaining glucose is converted to fat for long-term storage.
Amino acid metabolism: Some amino acids are used to build proteins and peptides, while the remainder are converted to fat and stored in adipose tissue.
Fat metabolism: Dietary fats are not used for energy during the absorptive phase but are stored directly in adipose tissue.
Short-term energy reservoir: Located in the liver, stores energy as glycogen to supply the brain during brief fasting periods between meals.
Long-term energy reservoir: Located in adipose tissue, stores energy as triglycerides to supply the brain and body during prolonged fasting.
In the fasting phase: Insulin levels drop, glucagon and catecholamines rise, leading to the breakdown of liver glycogen into glucose (used mainly by the brain) and triglycerides into fatty acids and glycerol (used by the rest of the body); glycerol can be converted to glucose by the liver.
Nutrient conversion and storage: Excess carbohydrates and amino acids can be converted to fat, highlighting the body's ability to shift nutrients between reservoirs and forms depending on metabolic needs.
What Starts a Meal?
Eating behavior is influenced by multiple factors, including both environmental cues and internal physiological processes.
Environmental factors such as the presence of food, social context, and visual cues can affect when you start eating and how much you consume.
Internal signals from your stomach, digestive system, and metabolic responses play a key role in compelling you to eat, regulating hunger and satiety.
Environmental Factors
Environmental signals play a major role in initiating meals, with ancestral environments favoring mechanisms that quickly detect energy deficits and strongly motivate eating to prevent starvation.
Internal cues such as stomach and upper intestine emptiness send hunger signals to the brain, prompting you to start eating, especially when food is readily available.
External cues—including the sight and smell of food, social presence, and meal-related cues (like being told "It's time to eat")—also trigger eating behavior, often independent of true physiological hunger.
Patterns of meal timing, such as eating three times a day, are influenced by both physiological factors (how long it takes for the stomach to empty) and social traditions (group meal preparation and communal eating).
Mechanisms to detect and respond to weight loss are evolutionarily stronger than those that suppress overeating, due to the historical threat of starvation being greater than that of overeating.
Gastric Factors
Ghrelin is a peptide hormone released primarily from the stomach during fasting or when the digestive system is empty, signaling the brain to initiate eating.
Ghrelin binds to receptors in the hypothalamus, stimulating eating behavior and increasing thoughts about food.
Blood levels of ghrelin rise before meals and decrease after eating, indicating its role in meal initiation.
Blocking ghrelin reduces eating, while increasing ghrelin can lead to weight gain by boosting food intake and decreasing fat metabolism.
In Prader-Willi syndrome, chronically high ghrelin levels are associated with continuous overeating and obesity; drugs like AZP-531 that inhibit ghrelin’s effects can improve food-related behaviors.
Ghrelin is not the only hunger signal; people with low ghrelin after gastric bypass still eat, and mice lacking ghrelin or its receptor maintain normal food intake and weight, though they are protected from diet-induced obesity.
Multiple, redundant systems regulate feeding, making ingestive behavior complex and not solely dependent on ghrelin.
Metabolic Signals
Metabolic signals play a key role in starting a meal, especially after extended periods without food. As time passes after a meal, your body shifts from using nutrients absorbed from the digestive tract (absorptive phase) to drawing on long-term nutrient reservoirs—glucose for the brain and fatty acids for the rest of the body.
A drop in blood glucose (hypoglycemia) is a strong trigger for hunger. Hypoglycemia can be experimentally induced by insulin or by 2-deoxyglucose (2-DG), which blocks glucose metabolism. Both methods cause glucoprivation (glucose deprivation), which stimulates eating.
Hunger can also be triggered by lipoprivation, or deprivation of fatty acids. This can be induced by drugs like mercaptoacetate, which block fatty acid metabolism.
There are two main sets of nutrient detectors: one in the brain and one in the liver. The brain’s detectors are sensitive only to glucose (since the brain cannot use fatty acids), while the liver’s detectors respond to both glucose and fatty acid levels.
Liver detectors send hunger signals to the brain via the vagus nerve. Experiments show that infusing 2-DG into the liver or blocking fatty acid metabolism triggers eating, but cutting the vagus nerve abolishes these effects, indicating the liver communicates nutrient status to the brain through this pathway.
The brain also contains its own glucose-sensitive detectors, particularly in the hindbrain (dorsomedial and ventrolateral medulla). Directly inducing glucoprivation in these regions stimulates eating.
No single set of receptors is solely responsible for controlling eating. Disrupting ghrelin signaling, cutting the hepatic branch of the vagus nerve, or lesioning the medulla does not completely abolish normal eating behavior, indicating multiple redundant mechanisms regulate hunger and food intake.
Environmental and gastric factors also contribute to meal initiation. Environmental cues (time of day, social context, sensory signals) and the hormone ghrelin (released by the empty stomach and upper intestine) both stimulate eating, with ghrelin levels rising before meals and falling during the absorptive phase.
Overall, hunger is regulated by a combination of metabolic signals (glucoprivation and lipoprivation), environmental cues, and hormonal signals, with multiple overlapping systems ensuring reliable control of food intake.
What Stops a Meal?
Body weight is regulated by balancing food intake and energy expenditure; consuming more calories than you burn leads to weight gain.
Carbohydrates and proteins provide about 4 kcal/g, while fats provide about 9 kcal/g; the "calorie" on food labels refers to a kilocalorie (1,000 calories).
Maintaining constant body weight requires two mechanisms: one increases motivation to eat when nutrient reserves are low, and the other restrains food intake when excess calories are consumed; the drive to eat when reserves are low is generally stronger than the drive to stop eating when reserves are high.
Satiety signals help regulate eating and are divided into short-term and long-term signals.
Short-term satiety signals stop a single meal and come from sensory information (eyes, mouth, nose), environmental factors (such as meal frequency), the liver, gastric factors, and the intestines.
Long-term satiety signals originate from adipose (fat) tissue and help control overall calorie intake by influencing how the brain responds to hunger and satiety cues over time.
Short-Term Satiety
Short-term satiety signals help regulate when you stop eating during a meal, independent of the body's long-term energy needs.
Short-term memory plays a crucial role in satiety, as shown by Patient B. R., who, due to memory impairment, could eat multiple meals in succession without recalling previous ones, indicating that memory of recent eating contributes to feeling full.
Short-term satiety signals originate from multiple sources along the digestive pathway:
Sensory cues from the eyes, nose, and mouth (such as sight, smell, and taste of food) provide initial feedback to the brain about food intake.
The stomach sends signals based on its stretch and the presence of food, indicating fullness.
The small intestine and liver also contribute signals as food progresses through digestion, further informing the brain about ongoing nutrient absorption.
Environmental factors, such as the context and cues surrounding eating, can influence short-term satiety by affecting how these signals are perceived and processed.
Environmental Factors
Environmental factors can significantly influence how much you eat, often increasing meal size.
Key factors that contribute to increased eating include: the tastiness of food, eating with others, larger portion sizes, and eating meals later in the day.
Sensory aspects of eating, such as the visual and tactile properties of cutlery (weight, size, color, shape), can alter your perception of taste and how much you like the food, even when the food itself is identical.
These environmental cues act as regulators of short-term satiety, often overriding the body's weaker mechanisms to stop eating.
Sensory Factors
Sensory factors such as appearance, odor, taste, texture, and temperature of food contribute to satiety (the feeling of fullness).
Taste and odor help you learn about the caloric content of foods, influencing how full you feel.
The physical act of tasting and swallowing food increases satiety more than simply having food in your stomach, as shown by studies comparing eating versus direct stomach infusion.
Taste and smell (chemosenses) work together to shape your eating experience and sense of fullness.
Reduced taste and smell perception, especially in older adults, can decrease appetite and lead to weight loss; enhancing these senses in food can help maintain appetite and nutritional status.
Gastric Factors
The stomach contains receptors that detect the presence of nutrients, allowing it to provide satiety signals.
Experiments with rats showed that when food was removed from their stomachs after eating, they would eat again to replace exactly the amount removed, indicating the ability to monitor stomach contents.
Rats did not respond to nonnutritive saline infusions as if it were food, suggesting that the stomach detects nutrients, not just volume.
Human studies found that infusing glucose into the stomach (but not the intestine) increased feelings of fullness and reduced hunger, supporting the role of stomach nutrient receptors in satiety.
The stomach and digestive tract release the hormone ghrelin, which is high before meals and decreases after eating, contributing to the feeling of satiety.
Intestinal Factors
The intestines provide satiety signals through nutrient detectors in the duodenum, which are sensitive to glucose, amino acids, and fatty acids, and can send signals to the brain indicating fullness.
Stomach and intestinal satiety factors interact, as shown by studies where the presence of nutrients (fats or carbohydrates) in the duodenum increased sensations of fullness beyond just stomach distension.
Nutrients in the small intestine act as a "brake" to reduce eating behavior via negative feedback, which is being explored as a potential intervention for obesity.
The duodenum regulates stomach emptying by secreting cholecystokinin (CCK) in response to fats. CCK causes the gallbladder to contract, the pylorus to constrict, and inhibits gastric contractions, thus slowing the entry of more food into the duodenum.
CCK may signal satiety to the brain indirectly; it acts on receptors at the stomach-duodenum junction, and its appetite-suppressing effects are transmitted via the vagus nerve. Destruction of these sensory axons abolishes CCK’s effect.
Suppression of the hunger hormone ghrelin occurs when food enters the duodenum, reducing hunger and contributing to meal termination.
Peptide YY3-36 (PYY) is released by the small intestine after a meal in proportion to caloric intake, and only nutrients—not water—trigger its release. PYY injections decrease meal size in both animals and humans.
Higher PYY levels after a meal correlate with greater feelings of satiety, and experimental data show that individuals consume fewer calories after PYY administration compared to saline, demonstrating its role in reducing food intake.
Liver Factors
Late-stage satiety signals originate in the liver, which detects nutrients arriving from the intestines after absorption.
Satiety signals from the stomach and duodenum are anticipatory, predicting future nutrient absorption, but true satiety occurs only when nutrients are actually absorbed and available to nourish body cells.
Experimental evidence shows that infusing glucose and fructose into the hepatic portal vein reduces food intake, indicating the liver's role in signaling satiety to the brain.
Fructose, which is metabolized primarily by the liver and cannot cross the blood–brain barrier, demonstrates that the satiety signal must come from the liver when it detects incoming nutrients.
The liver's satiety signal reinforces and continues the satiety initiated by earlier signals from the stomach and upper intestine.
Insulin
Insulin acts as a satiety signal by informing the brain that the body is in the absorptive phase of metabolism, when nutrient levels are high.
Insulin receptors in the brain, particularly in the hypothalamus, detect insulin in the blood, even though brain cells do not require insulin to metabolize glucose.
Insulin crosses the blood–brain barrier via a specific transport mechanism and influences neurons that regulate hunger and satiety.
Experimental infusion of insulin into the brain's third ventricle reduces food intake and leads to weight loss, demonstrating its role in promoting satiety.
Mice lacking insulin receptors in the brain (but not elsewhere) become obese, especially on high-fat diets, indicating that brain insulin signaling is crucial for normal satiety and body weight regulation.
Adipose Tissue Factors
Short-term satiety signals regulate the size of a single meal and originate from immediate physiological responses to eating, including sensory input (appearance, taste, smell, texture, temperature), gastric and intestinal nutrient detection, and hormonal changes such as decreased ghrelin, increased CCK, and PYY secretion.
Environmental and sensory factors like food palatability, social context, portion size, and meal timing can influence how much you eat in a single meal by affecting short-term satiety.
Gastric and intestinal satiety are triggered by food entering the stomach and duodenum, activating nutrient detectors and releasing hormones (e.g., CCK, PYY) that signal fullness to the brain via the vagus nerve.
Liver satiety signals occur later in the meal process, as the liver detects nutrients arriving from the intestines through the hepatic portal vein, contributing to the feeling of fullness.
Insulin acts as a satiety signal during the absorptive phase of metabolism; moderately high insulin levels signal the brain to reduce food intake, while very high levels can paradoxically trigger eating by lowering blood glucose.
Long-term satiety signals arise from adipose (fat) tissue and help regulate overall body weight by modulating the brain’s sensitivity to hunger and short-term satiety signals, rather than controlling meal size directly.
Leptin, a peptide hormone secreted by well-nourished fat cells, is a key long-term satiety signal; it increases metabolic rate, raises body temperature, boosts activity, and decreases food intake, helping maintain stable body weight.
Genetic studies in ob mice revealed that a lack of leptin production leads to obesity, overeating, and low metabolism; leptin injections in these mice restore normal weight and metabolic function.
Force-feeding and dieting experiments show that animals adjust their food intake to maintain stable body weight, indicating that signals from body fat (like leptin) play a crucial role in long-term energy balance.
Short-term and long-term satiety signals interact, with long-term signals from adipose tissue influencing how effective short-term signals are at stopping or initiating meals.
Brain Mechanisms
Hunger and satiety signals are generated by the digestive system and nutrient reservoirs in your body.
These signals are directed toward your brain, which acts as the central target for regulating food intake and metabolism.
Research focuses on understanding the brain mechanisms that control how much you eat and how your body processes nutrients.
Brain Stem
The brain stem, specifically the hindbrain, contains neural circuits essential for basic ingestive behaviors such as chewing and swallowing. These behaviors can occur even in decerebrate animals (where the forebrain is disconnected), indicating their control by ancient brain mechanisms.
Decerebrate rats can perform ingestive actions like swallowing and taste discrimination, but cannot initiate food-seeking behaviors. They can distinguish between sweet, salty, and bitter tastes, and their ingestive responses are influenced by hunger and satiety signals.
The area postrema and nucleus of the solitary tract (AP/NST) in the medulla play a key role in eating regulation. These regions receive taste information from the tongue and sensory signals from internal organs (stomach, duodenum, liver), including glucose levels.
The AP/NST can detect hunger and satiety signals and control aspects of food intake. For example, decerebrate rats increase sucrose intake after food deprivation and decrease it if sucrose is injected into their stomachs.
Lesions in the AP/NST abolish feeding responses to both glucoprivation (lack of glucose) and lipoprivation (lack of lipids), demonstrating the necessity of this region for detecting and responding to energy deficits.
Information from the AP/NST is relayed to forebrain regions that further regulate eating and metabolism, showing an integrated system between the brain stem and higher brain areas for ingestive behavior control.
Hypothalamus
The hypothalamus regulates eating through two main regions: the lateral hypothalamus (controls hunger) and the ventromedial hypothalamus (controls satiety). Stimulating the lateral hypothalamus triggers eating, while damaging it stops eating; damaging the ventromedial hypothalamus causes overeating, while stimulating it suppresses eating.
Hunger is promoted by neuropeptides MCH and orexin, produced in the lateral hypothalamus. These peptides stimulate appetite and lower metabolic rate, helping to increase and preserve energy stores. MCH and orexin are increased during food deprivation and decreased after eating.
Neuropeptide Y (NPY) is a powerful hunger signal, produced mainly in the arcuate nucleus. NPY stimulates intense eating behavior and is increased by food deprivation, glucoprivation, and ghrelin (a hormone released by the empty stomach). NPY neurons activate MCH and orexin neurons, further promoting hunger.
Agouti-related protein (AGRP) is another orexigenic peptide, released by NPY neurons. AGRP acts with NPY to stimulate long-lasting increases in food intake.
Endocannabinoids (like those mimicked by THC in marijuana) also stimulate appetite by increasing the release of MCH and orexin. Endocannabinoid levels are highest during fasting and lowest after feeding.
Ghrelin, released by the stomach when empty, activates NPY/AGRP neurons and also stimulates dopamine neurons in the ventral tegmental area, linking hunger to motivation and reward.
Satiety is regulated by the ventromedial hypothalamus, where signals converge to inhibit eating. Key satiety signals include leptin (from fat tissue), which suppresses eating and increases metabolic rate by inhibiting NPY/AGRP neurons and reducing MCH and orexin release.
CART (cocaine- and amphetamine-regulated transcript) and α-MSH (alpha-melanocyte-stimulating hormone) are anorexigenic peptides produced in the arcuate nucleus. CART suppresses eating and increases metabolism, partly by inhibiting MCH and orexin neurons. α-MSH inhibits eating by activating MC4 receptors, counteracting the effects of AGRP.
Leptin and insulin inhibit orexigenic (appetite-stimulating) neurons and stimulate anorexigenic (appetite-suppressing) neurons in the hypothalamus, leading to reduced food intake.
Multiple feedback loops and hormonal signals (ghrelin, leptin, insulin, PYY) interact with hypothalamic circuits to balance hunger and satiety, integrating signals from the stomach, intestines, pancreas, and fat tissue.* Leptin, produced by fat tissue, inhibits NPY/AGRP neurons and activates CART/α-MSH neurons in the arcuate nucleus, leading to suppression of eating and increased metabolic rate. Leptin also indirectly inhibits MCH and orexin neurons in the lateral hypothalamus, further reducing appetite.
PYY, released by the gastrointestinal tract after a meal, inhibits orexigenic NPY/AGRP neurons, contributing to satiety and reduced food intake.
Ghrelin, produced by the gastrointestinal system, activates NPY/AGRP neurons and inhibits CART/α-MSH neurons, directly increasing appetite and reducing the anorexigenic effect of CART/α-MSH.
Orexin and MCH, secreted by neurons in the lateral hypothalamus, are activated by NPY/AGRP and inhibited by leptin and CART/α-MSH; both peptides stimulate eating and decrease metabolic rate.
NPY and AGRP, produced in the arcuate nucleus, stimulate eating and decrease metabolic rate; NPY is activated by ghrelin and inhibited by leptin, while AGRP acts as an antagonist at MC4 receptors.
CART and α-MSH, also from the arcuate nucleus, are activated by leptin and suppress eating while increasing metabolic rate; α-MSH acts as an agonist at MC4 receptors.
Insulin, produced by the pancreas, has effects similar to leptin in suppressing eating and increasing metabolic rate.
Cholecystokinin (CCK), released from the duodenum, suppresses eating by acting on neurons in the pylorus.
Appetite is regulated by a balance between orexigenic (appetite-stimulating) and anorexigenic (appetite-suppressing) factors, with key interactions among neuropeptides and peripheral peptides.
The brain stem, particularly the area postrema and nucleus of the solitary tract (AP/NST), receives signals from the digestive system and helps control food intake; lesions here disrupt both glucose- and lipid-driven eating.
The lateral hypothalamus initiates eating via orexin and MCH neurons, while the ventromedial hypothalamus regulates satiety.
NPY neurons in the arcuate nucleus are the primary target of ghrelin and are involved in both hunger signaling and metabolic rate regulation; blocking NPY receptors suppresses eating.
Endocannabinoids stimulate eating by increasing MCH and orexin release.
Leptin desensitizes the brain to hunger signals by inhibiting NPY neurons and activating CART/α-MSH neurons, leading to increased metabolic rate and suppressed eating.
CART/α-MSH neurons inhibit MCH and orexin neurons, further suppressing appetite.
PYY suppresses the release of NPY and AGRP, contributing to satiety.
Ghrelin not only stimulates hunger via NPY/AGRP but also inhibits the satiating effect of CART/α-MSH.
The paraventricular nucleus, when excited by anorexigenic peptides, activates brain stem nuclei that control the autonomic nervous system, resulting in decreased insulin secretion, decreased breakdown of fatty acids, and decreased body temperature.
Obesity
Obesity rates are rising globally, affecting both adults and children, with over 1.9 billion adults overweight and 650 million obese as of 2016; 39% of adults are overweight and 13% are obese, and 380 million children/adolescents are affected.
Obesity increases risk for serious health conditions such as cardiovascular disease, diabetes (including type II diabetes now seen in children), stroke, arthritis, and certain cancers.
Body Mass Index (BMI) is a key tool for assessing weight-related health risks, calculated as or . BMI categories are: underweight (<18.5), healthy (18.5–25), overweight (>25), and obese (>30).
Case study of a 17-year-old with severe obesity (BMI 53) demonstrates the impact of gastric surgery: After sleeve gastrectomy, significant weight loss occurred (total of 51.6 kg over 24 months), BMI reduced to 35, and both visceral and subcutaneous fat decreased.
Health improvements post-surgery included normalization of liver enzymes and insulin resistance, indicating better liver function and reduced risk for type II diabetes.
Gastric surgery not only reduces stomach size but also affects hunger and satiety signals in the brain, leading to reduced hunger, fewer cravings, and lower levels of appetite-regulating hormones (ghrelin and leptin).
Treating obesity is complex and challenging; while diet and exercise work for some, others may require surgical interventions, which themselves are not universally effective. Multiple factors influence obesity and its treatment.
Possible Causes
Obesity results from a complex interplay of genetics, environment, and physical activity. Extreme obesity is often linked to genetic differences affecting the endocrine system and brain mechanisms that regulate food intake and metabolism, but the global rise in obesity is primarily due to rapid environmental changes rather than genetic shifts.
Environmental factors significantly contribute to obesity. Readily available, inexpensive, high-calorie foods, increased portion sizes, and frequent eating out (especially at fast-food restaurants) promote higher calorie intake. High-fructose corn syrup in many foods does not trigger satiety signals as effectively as glucose, leading to increased consumption.
Lifestyle transitions, such as starting college, can lead to weight gain. Studies show that most college students gain weight, increase BMI, and body fat percentage, especially in the first year, often due to reduced fruit and vegetable intake and less vigorous physical activity, particularly among those living off campus.
Food deserts exacerbate obesity rates. In areas lacking access to fresh, healthy foods, people rely more on processed, calorie-dense foods, increasing the risk of obesity and related health problems.
Physical activity levels have declined, reducing energy expenditure. Modern sedentary lifestyles mean people burn fewer calories than previous generations, contributing to weight gain even if calorie intake is only slightly reduced.
Nonexercise activity thermogenesis (NEAT) plays a key role in energy expenditure. NEAT includes involuntary activities like fidgeting and posture changes. Higher NEAT levels are associated with less fat gain, and interventions like treadmill desks can increase NEAT, promote weight loss, and reduce waist circumference.
Genetics strongly influence body weight and metabolic efficiency. Twin studies estimate that 40–70% of body fat variability is genetic. Most obesity-related genes have small individual effects, but collectively they contribute to heritability. The "thrifty phenotype" describes individuals with efficient metabolisms who store excess calories as fat, while "spendthrift phenotypes" burn more calories and gain less weight.
Genetic predispositions interact with environment. Populations with historically scarce food supplies may have evolved efficient metabolisms, which become a liability in modern environments with abundant, calorie-rich foods, as seen in studies of Pima populations in the U.S. and Mexico.
Leptin, a hormone produced by fat tissue, regulates hunger and metabolism. Rare genetic mutations causing leptin or leptin receptor deficiencies can lead to obesity, but most obese individuals have high leptin levels and are resistant to its effects. Leptin resistance is associated with the "thrifty" metabolism, allowing continued weight gain despite high leptin.
A drop in leptin signals hunger and increases orexigenic (appetite-stimulating) peptides, while high leptin should suppress appetite, but this mechanism is impaired in leptin-resistant individuals.
Treatment
Obesity is challenging to treat due to physiological mechanisms similar to those involved in drug addiction, with reinforcement and stress playing key roles in relapse; both dopamine (reinforcement) and corticotrophin-releasing hormone (CRH, stress) are implicated in the reinstatement of overeating, and stress can trigger relapse in both food and drug-seeking behaviors.
Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), is effective for significant and sustained weight loss, typically resulting in an average loss of about 35% of initial weight and improvements in health conditions like hypertension and diabetes; RYGB works by creating a small stomach pouch connected to the jejunum, bypassing the duodenum, which disrupts ghrelin secretion (reducing hunger) and increases PYY (enhancing satiety), but may cause deficiencies in iron and vitamin B12.
Pharmacological interventions target appetite suppression, fat absorption, and reinforcement mechanisms, but many drugs have been withdrawn due to serious side effects:
Serotonergic agonists (e.g., fenfluramine, sibutramine) suppressed appetite but were withdrawn for cardiovascular risks.
Rimonabant (CB1 antagonist) reduced appetite and improved metabolic markers but was withdrawn due to psychiatric side effects.
Celastrol and other leptin-sensitizing compounds show promise in animal studies for reducing food intake.
Orlistat inhibits fat absorption, leading to weight loss and reduced diabetes risk, but causes gastrointestinal side effects in 15–30% of users.
The combination of naltrexone (opioid antagonist) and bupropion (dopamine agonist) significantly increases weight loss and improves cardiovascular health compared to placebo.
Behavioral interventions, especially exercise, are beneficial for weight management, as regular aerobic exercise reduces body fat and increases daily energy requirements, with greater effects observed in lean individuals compared to obese individuals.* Exercise programs can reduce body fat and increase bone density in children with obesity, and even small increases in daily physical activity (e.g., 14 minutes of walking, expending 100 kcal) can help prevent weight gain in most people.
Behavioral interventions for weight loss include health coaching, cognitive behavioral therapy, and incentive programs, alongside surgical and pharmacological treatments, reflecting the complexity and persistence of obesity.
Eating is reinforced by pleasure, and satiety signals are often ignored, making it challenging to regulate food intake; understanding hunger and satiety physiology is key to developing better interventions.
Environmental factors such as easy access to high-calorie foods and reduced physical activity contribute significantly to obesity, with NEAT (nonexercise activity thermogenesis) also playing a role.
Genetic and environmental interactions are evident: for example, Pima people in the U.S. (high-fat diet, less activity) have higher obesity and diabetes rates than Pima in Mexico (low-fat diet, subsistence farming).
Heredity strongly influences obesity, with some individuals inheriting a "thrifty" metabolism (low NEAT), making weight loss more difficult.
Obesity due to leptin or leptin receptor deficiency is rare, but most obese individuals have high leptin levels and are resistant to its effects, likely due to impaired transport across the blood-brain barrier.
Key genetic causes of severe obesity include mutations in the MC4 receptor and FTO gene, which affect hypothalamic regulation of energy balance; mutations affecting leptin or its receptor also cause obesity.
Stress and anxiety can trigger relapse into overeating or drug use, involving dopamine (reinforcement) and CRH (stress) pathways.
No single treatment for obesity is universally effective; approaches include behavioral, surgical, and pharmacological methods.
RYGB (Roux-en-Y gastric bypass) surgery is effective, likely by reducing ghrelin (hunger hormone) and increasing PYY (satiety hormone).
Some drugs (fenfluramine, rimonabant) suppress appetite but have serious side effects, limiting their use; orlistat reduces fat absorption and is currently used.
Ongoing research focuses on targeting orexigenic and anorexigenic pathways to develop safer and more effective anti-obesity medications.
Eating Disorders
Eating disorders include anorexia nervosa, bulimia nervosa, and binge-eating disorder, each involving extreme changes in eating behavior and significant health risks.
Anorexia nervosa is characterized by restricted eating leading to low body weight, intense fear of gaining weight, persistent behaviors to prevent weight gain, and a distorted self-perception or lack of recognition of the seriousness of low body weight.
Bulimia nervosa involves episodes of binge eating followed by compensatory behaviors (such as vomiting or laxative use) to prevent weight gain, and a critical evaluation of body weight or shape.
Binge-eating disorder is marked by episodes of binge eating and distress about bingeing, but without compensatory behaviors like purging.
Prevalence rates are estimated at 0.5–2% for anorexia nervosa, 1–3% for bulimia nervosa, and 2–7% for binge-eating disorder.
Women are significantly more likely than men to develop anorexia nervosa (10–20 times) and bulimia nervosa (about 10 times), while binge-eating disorder affects men and women at similar rates.
Eating disorders are associated with increased mortality, especially in anorexia nervosa, higher suicide rates, reduced quality of life, frequent hospitalizations, and substantial health care costs.
The causes of eating disorders are not fully understood but likely involve both environmental and genetic factors.
The DSM-5 classifies these conditions under Feeding and Eating Disorders, defined by persistent eating behaviors that impair physical health or psychosocial functioning; obesity is not classified as a mental illness.
Treatment is challenging, with many individuals requiring repeated interventions and experiencing low success rates; cognitive behavioral therapy can be effective in reducing symptoms.
Possible Causes
Anorexia nervosa involves intense preoccupation with food and an extreme fear of gaining weight, despite significant weight loss. Individuals may engage in ritualistic behaviors around food, excessive exercise, and persistent dieting.
Brain changes in anorexia include loss of gray and white matter, enlarged ventricles, and widened sulci, indicating brain tissue shrinkage. These changes can be partially reversed with successful treatment and weight restoration.
Starvation itself can produce many symptoms seen in eating disorders, such as food obsession, ritualistic eating, mood swings, depression, insomnia, and social withdrawal. The Minnesota semistarvation study showed that healthy men developed these symptoms when subjected to prolonged caloric restriction, supporting the idea that many eating disorder symptoms are consequences of starvation rather than causes.
Excessive exercise is common in anorexia and may be a symptom of starvation rather than a deliberate weight-loss strategy. Animal studies show that food-restricted rats increase activity, likely as an innate food-seeking behavior. Elevated neuropeptide Y (NPY) levels in anorexia may drive both increased activity and food obsession.
Genetic factors play a significant role in the development of anorexia nervosa, with heritability estimates between 58% and 76%. Twin studies and higher incidence in those with birth complications support a biological predisposition, though environmental and social factors (such as cultural emphasis on thinness) also contribute.
Restricted access to food can trigger anorexia-like behaviors in predisposed individuals. Some participants in the Minnesota study developed dieting behaviors and body dissatisfaction after the period of starvation, suggesting that severe caloric restriction can induce symptoms in vulnerable people.
There are gender differences in response to food deprivation: after fasting, men tend to eat more, while women may eat less. This difference may contribute to the higher prevalence of anorexia in young women and could be influenced by hormonal or social factors.
Treatment
Cognitive behavioral therapy (CBT) is widely used for eating disorder treatment, especially effective for bulimia, but has a success rate of less than 50% and a 22% relapse rate within one year.
Pharmacological treatments have limited effectiveness for anorexia nervosa; drugs that increase appetite (e.g., antipsychotics, adrenergic receptor stimulants, l-DOPA, THC) are generally ineffective, likely because anorexia is not caused by lack of hunger.
Serotonin agonists like fluoxetine (an SSRI) can help treat bulimia nervosa, but are not effective for anorexia nervosa.
Lisdexamfetamine (LDX), an amphetamine, is effective for binge-eating disorder, reducing both binge eating episodes and relapse rates, and altering brain responses to food cues.
Alternative therapies show promise, especially for anorexia nervosa: one protocol involves teaching patients to eat at a normal pace using a computerized scale and providing a warm environment post-meal, resulting in a 75% success rate, 10% relapse, and 0% mortality.
Deep brain stimulation of the cingulate cortex has improved mood, BMI, and neural function in treatment-resistant anorexia nervosa after one year.
Oxytocin administration may reduce distress and some symptoms in anorexia nervosa, with evidence of lower stress hormone (cortisol) levels after treatment.
Eating disorders are linked to both biological and environmental factors, including brain changes (enlarged ventricles, reduced brain volume), symptoms of starvation, excessive exercise, birth complications, and genetic predisposition (supported by twin studies).
Most treatments have low success rates, but some alternative therapies have demonstrated higher effectiveness compared to traditional approaches.
Chapter Review Questions
Regulatory mechanisms maintain homeostasis by detecting deviations from a set point, integrating this information, and activating effectors to correct the imbalance.
Body fluid compartments include intracellular fluid (inside cells) and extracellular fluid (outside cells, such as interstitial fluid and plasma). Osmometric thirst is triggered by increased solute concentration in the extracellular fluid, while volumetric thirst is caused by a decrease in blood volume.
Neural control of thirst involves the hypothalamus, which detects changes in osmolarity and blood volume and initiates thirst responses.
Short-term energy reservoirs store glycogen in the liver and muscles, while long-term reservoirs store fat in adipose tissue. The absorptive phase occurs after eating, when nutrients are stored, and the fasting phase occurs when the body uses stored energy.
Social and environmental factors (such as time of day, presence of others, and food cues) and internal hunger signals (like ghrelin release) can initiate eating.
Meal termination is influenced by factors such as stomach distension, nutrient detection in the gut, and hormonal signals (e.g., cholecystokinin, insulin, and leptin).
The brain stem and hypothalamus play key roles in hunger regulation, integrating peripheral signals and coordinating feeding behavior.
The hypothalamus is also crucial for satiety, responding to hormonal and nutrient signals to inhibit further eating.
Obesity can result from genetic predisposition, metabolic factors, environmental influences, and behavioral patterns.
Treatments for obesity include surgical interventions (e.g., bariatric surgery), pharmacological agents (e.g., appetite suppressants), and behavioral modifications (e.g., diet and exercise).
Eating disorders may be influenced by physiological factors such as neurotransmitter imbalances, hormonal dysregulation, and genetic vulnerability.